BLRX - BioLine Rx Ltd

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts4444
Avg. Estimate-0.05-0.06-0.24-0.02
Low Estimate-0.06-0.06-0.25-0.24
High Estimate-0.05-0.05-0.230.39
Year Ago EPS-0.08-0.07-0.28-0.24
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts4444
Avg. EstimateN/AN/AN/A2.55M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A8.7M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.07-0.08-0.06-0.06
EPS Actual-0.08-0.07-0.08-0.05
Difference-0.010.01-0.020.01
Surprise %-14.30%12.50%-33.30%16.70%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.05-0.06-0.24-0.02
7 Days Ago-0.05-0.06-0.24-0.02
30 Days Ago-0.05-0.06-0.24-0.02
60 Days Ago-0.05-0.06-0.24-0.02
90 Days Ago-0.06-0.06-0.240.05
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesBLRXIndustrySectorS&P 500
Current Qtr.37.50%N/AN/A0.16
Next Qtr.14.30%N/AN/A0.27
Current Year14.30%N/AN/A0.07
Next Year91.70%N/AN/A0.12
Next 5 Years (per annum)-25.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A